Newstral
PMPRB
- Discussion Guide for PMPRB Phase 2 Consultations on New Guidelines outlines proposed new framework for patented medicine price reviewjdsupra.com
- Federal Court finds PMPRB reasonably concluded Galderma’s patent claiming 0.3% adapalene “pertained to” 0.1% adapalene DIFFERINjdsupra.com
- PMPRB publishes scoping paper for consultation on guidelines, and invites stakeholder feedbackjdsupra.com
- Health minister accused of meddling in work of drug price review boardCBC
- New PMPRB Guidelines will not be implemented January 1, 2023jdsupra.com
- PMPRB releases 2020 Annual Report and April 2022 NEWSletterjdsupra.com
- PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPsjdsupra.com
- Few significant changes made in final PMPRB Guidelinesjdsupra.com
- Federal Court strikes price calculation provision of amendments to Patented Medicines Regulationsjdsupra.com
- PMPRB releases three new NPDUIS reportsjdsupra.com
- PMPRB News: “significant changes” to be made to draft pricing Guidelinesjdsupra.com
- AB.C. applauds federal government for modernizing drug pricing regulationsasianjournal.ca
- VFederal government announces changes to lower drug pricesvoiceonline.com
- Federal Court upholds PMPRB’s pricing decision regarding Alexion’s SOLIRISjdsupra.com
- Withdrawal symptoms: Could lower drug prices hurt more than just big pharma?business.financialpost.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.